REVERSAL OF SEVERE VENOM-INDUCED CONSUMPTIVE COAGULOPATHY FOLLOWING DELAYED ANTIVENOM ADMINISTRATION IN A PEDIATRIC GREEN PIT VIPER ENVENOMATION

Main Article Content

Ahmadal Mustafa
Yuddy Imowanto

Abstract

Background. Green pit viper (Trimeresurus spp.) envenomation can cause venom-induced consumptive coagulopathy (VICC), for which species-specific antivenom is the cornerstone of therapy. The standard Indonesian trivalent antivenom does not cover Trimeresurus. This report aims to describe the presentation, antivenom dosing, and hematologic recovery of a child with severe VICC after a green pit viper bite and ineffective trivalent antivenom.


Case. A 3-year-old boy (15 kg) was referred to a tertiary hospital three days after a finger bite, with swelling of the entire right arm. At a district hospital, coagulation was initially normal (PT 13.1 s, platelets 440,000/µL), and trivalent antivenom produced no improvement.


Findings. On referral (Day 0), PT and APTT exceeded 180 s, INR was unmeasurable, and platelets were 6,000/µL. A green snake with a red tail was described, and green pit viper envenomation was diagnosed clinically. Because of limited stock, he received two vials of monovalent green pit viper antivenom on Day 0 (platelets 10,000/µL on Day 1), followed by three vials on Day 1. By Day 2, platelets were 63,000/µL, PT 10.7 s, APTT 15.8 s, and INR 0.99; platelets reached 163,000/µL on Day 4. No transfusion or antivenom reaction occurred, and he was discharged on Day 10.


Conclusion. Coagulopathy resolved after species-specific antivenom despite a 72-hour delay, whereas non-specific antivenom had no apparent effect. This case supports antivenom selection guided by clinical toxinology, adult-equivalent vial dosing in children, and repeat coagulation testing, particularly in resource-limited settings.

Article Details

How to Cite
Mustafa, A., & Imowanto, Y. (2026). REVERSAL OF SEVERE VENOM-INDUCED CONSUMPTIVE COAGULOPATHY FOLLOWING DELAYED ANTIVENOM ADMINISTRATION IN A PEDIATRIC GREEN PIT VIPER ENVENOMATION. SYNTHESIS Global Health Journal, 4(2), 97–108. https://doi.org/10.61543/syn.v4i2.205
Section
Articles
Author Biographies

Ahmadal Mustafa, Emergency Medicine Specialist Study Program, Faculty of Medicine, Universitas Brawijaya

Dr. Saiful Anwar General Hospital, Malang

Yuddy Imowanto, Emergency Medicine Specialist Study Program, Faculty of Medicine, Universitas Brawijaya

Dr. Saiful Anwar General Hospital, Malang

References

Warrell DA, Williams DJ. Clinical aspects of snakebite envenoming and its treatment in low-resource settings. Lancet. 2023;401(10385):1382-98. doi:10.1016/S0140-6736(23)00002-8

Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17063. doi:10.1038/nrdp.2017.63

Tan CH, Liew JL, Tan NH, Ismail AK, Maharani T, Khomvilai S, et al. Cross reactivity and lethality neutralization of venoms of Indonesian Trimeresurus complex species by Thai Green Pit Viper Antivenom. Toxicon. 2017;140:32-7. doi:10.1016/j.toxicon.2017.10.014

Wani A. Spectrum of snake bite, symptoms and its management: a review. Saudi J Med Pharm Sci. 2024;10(12):969-974. doi:10.36348/sjmps.2024.v10i12.014

Hutton RA, Looareesuwan S, Ho M, Silamut K, Chanthavanich P, Karbwang J, et al. Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. Trans R Soc Trop Med Hyg. 1990;84(6):866-74. doi:10.1016/0035-9203(90)90111-Q

Castillo DAE, Seneci L, Chowdhury A, Rimando MG, Fry BG. Bite first, bleed later: how Philippine Trimeresurus pit viper venoms hijack blood clotting. Toxins (Basel). 2025;17(4):185. doi:10.3390/toxins17040185

Kumar R, Haripriya V, Patra A, Kalita B, Vanuopadath M, Nair BG, et al. Proteomic and functional characterisation of Trimeresurus popeiorum (Pope’s pit viper) venom proteins: role of enzymatic and non-enzymatic venom toxins in envenomation pathophysiology. Int J Biol Macromol. 2025:140638. doi:10.1016/j.ijbiomac.2025.140638

Berling I, Isbister GK. Hematologic effects and complications of snake envenoming. Transfus Med Rev. 2015;29(2):82-9. doi:10.1016/j.tmrv.2014.09.005

Maduwage K, Isbister GK. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. PLoS Negl Trop Dis. 2014;8(10):e3220. doi:10.1371/journal.pntd.0003220

Le Geyt J, Pach S, Gutiérrez JM, Habib AG, Maduwage K, Hardcastle T, et al. Paediatric snakebite envenoming: recognition and management of cases. Arch Dis Child. 2021;106(1):14-9. doi:10.1136/archdischild-2020-319428

Oliveira IS, Pucca MB, Cerni FA, Vieira S, Sachett J, de Farias AS, et al. Snakebite envenoming in Brazilian children: clinical aspects, management and outcomes. J Trop Pediatr. 2023;69(2):fmad010. doi:10.1093/tropej/fmad010

Yang JYK, Hui H, Lee ACW. Severe coagulopathy associated with white-lipped green pit viper bite. Hong Kong Med J. 2007;13(5):392-5.

Essafti M, Fajri M, Rahmani C, Abdelaziz S, Mouaffak Y, Younous S. Snakebite envenomation in children: an ongoing burden in Morocco. Ann Med Surg (Lond). 2022;77:103574. doi:10.1016/j.amsu.2022.103574

Mayeden S, Wirth M, Agbaria N, Ali Shaikh M, Dambach P, Lowery Wilson M, et al. Pediatric snakebite in Sub-Saharan Africa: clinical predictors, outcomes, and gaps in care: a systematic review. PLoS Negl Trop Dis. 2026;20(2):e0013450. doi:10.1371/journal.pntd.0013450

Park EJ, Choi SC, Kim HH, Jung YS. Novel treatment strategy for patients with venom-induced consumptive coagulopathy from a pit viper bite. Toxins (Basel). 2020;12(5):295. doi:10.3390/toxins12050295

Lai R, Yan S, Wang S, Yang SQ, Yan ZR, Lan P, et al. The Chinese guideline for management of snakebites. World J Emerg Med. 2024;15(5):333-55. doi:10.5847/wjem.j.1920-8642.2024.076

Isbister GK. Snakebite doesn’t cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost. 2010;36(4):444-51. doi:10.1055/s-0030-1254053

Moon J, Chun B, Cho Y, Kim JC, Koo Y, Park KH, et al. Coagulopathy after snake envenomation in South Korea. Clin Toxicol (Phila). 2021;59:905-12. doi:10.1080/15563650.2021.1884694

Isbister GK, Scorgie FE, O’Leary MA, Seldon M, Brown SGA, Lincz LF. Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost. 2010;8(11):2504–2513. doi:10.1111/j.1538-7836.2010.04050.x

Valenta J, Hlavá?ková A, Stach Z, Štikarová J, Havlí?ek M, Michálek P. Fibrinogenolysis in venom-induced consumption coagulopathy after Viperidae snakebites: a pilot study. Toxins (Basel). 2022;14(8):538. doi:10.3390/toxins14080538

Wedasingha S, Isbister GK, Silva A. Bedside coagulation tests in diagnosing venom-induced consumption coagulopathy in snakebite. Toxins (Basel). 2020;12(9):583. doi:10.3390/toxins12090583

Alvitigala BY, Dissanayake HA, Weeratunga P, Padmaperuma PACD, Gooneratne L, Gnanathasan CA. Haemotoxicity of snakes: a review of pathogenesis, clinical manifestations, novel diagnostics and challenges in management. Trans R Soc Trop Med Hyg. 2025. doi:10.1093/trstmh/trae058

World Health Organization. Snakebite envenoming [Internet]. WHO; 2026. Available from: https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming